Mosspiration Biotech ApS: Financial statements 2023
CVR: 37414506
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Mosspiration Biotech ApS (CVR 37414506) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -6,233 and a net result of DKK -6,233 compared with DKK -20,393 the year before. Equity in the 2023 report amounted to DKK 4,088. The solvency ratio was 20.5%.
- Gross Profit
- DKK -6,233
- Profit/Loss
- DKK -6,233
- Equity
- DKK 4,088
- Total Assets
- DKK 19,983
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -6K | -6K | 4K | - |
| 2022 | - | -20K | -20K | 18K | - |
| 2021 | - | 12K | 12K | 34K | - |
| 2020 | - | 38K | 37K | 2K | - |
| 2019 | - | 51K | 9K | -35K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Mosspiration Biotech ApS has published its annual report for 2022. Gross profit came to DKK -20,331, and the net result was DKK -20,393.
About Mosspiration Biotech ApS
Mosspiration Biotech ApS was a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company has been dissolved on 14 August 2024. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named Mosspiration Biotech IVS. The company has 1 employee (2018). In 2023, the company reported a gross profit of DKK -6,233 and a net result of DKK -6,233 compared with DKK -20,393 the year before. Equity in the 2023 report amounted to DKK 4,088.